| Document Date: 2012-05-08 09:33:43
Open Document File Size: 862,39 KBShare Result on Facebook
City Salt Lake City / Seoul / / Country Korea / South Korea / / Facility Vincent Hospital / Catholic University / / IndustryTerm cancer therapy / / MedicalCondition colon cancer / tumor / xenograft tumor / choroidal neovascularization / cancer / tumors / Harvested tumors / subcutaneous tumors / macular degeneration / ocular diseases / neovascular-related disorders / / MedicalTreatment gene therapy / cancer therapy / / Organization Catholic University / UT 2John A. Moran Eye Center / Utah School of Medicine / Vincent Hospital / / Person Brian C. Hironori Bryce Taylor Christina / Tadashi Miya / Yang Kyung Cho / / Position Representative / / ProvinceOrState Utah / / Technology gene therapy / treating cancer / laser / /
SocialTag |
Shifting expression of membrane Vascular Endothelial Growth Factor Receptor-2 (mVEGFR2) to soluble Vascular Endothelial Growth Factor Receptor-2 (sVEGFR2) reduces CNV volume and tumor growth. 1,2 Stagg , Purpose